World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
36281
World Ranking
9609
National Ranking
4952

Overview

Gary J. Kelloff is affiliated with the National Institutes of Health in the United States, with a research focus spanning multiple fields within biomedical science. Their work concentrates primarily on cancer genomics and diagnostics, with significant contributions to lymphoma, multiple myeloma, and molecular biology techniques.

The main fields of study represented in their research include biochemistry, genetics, and molecular biology, alongside medicine. Subfields within their work encompass molecular biology, cancer research, pathology and forensic medicine, neurology, and oncology.

Key topics covered in their publications include:

  • Cancer Genomics and Diagnostics
  • Lymphoma Diagnosis and Treatment
  • CNS Lymphoma Diagnosis and Treatment
  • Molecular Biology Techniques and Applications
  • Single-cell and Spatial Transcriptomics
  • Sarcoma Diagnosis and Treatment
  • Multiple Myeloma Research and Treatments

Selected recent papers authored or co-authored by Gary J. Kelloff highlight a range of oncology and cancer diagnostic subjects. These include:

  • Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial, 2020, Blood
  • Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration, 2021, Clinical Cancer Research
  • Challenges to Using Big Data in Cancer, 2023, Cancer Research
  • Validation of ctDNA Quality Control Materials Through a Precompetitive Collaboration of the Foundation for the National Institutes of Health, 2021, JCO Precision Oncology
  • Case Studies for Overcoming Challenges in Using Big Data in Cancer, 2023, Cancer Research

Frequent co-authors in their research include Dana E. Connors, Caroline C. Sigman, Howard R. Higley, Stacey J. Adam, and Ilan R. Kirsch. These collaborations suggest interdisciplinary teamwork on cancer research challenges.

Their research is published in notable venues such as Cancer Research, Blood, Clinical Cancer Research, JCO Precision Oncology, and The Oncologist, reflecting a focus on oncological and translational medicine.

Best Publications

  • The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis

    Gideon Steinbach;Patrick M. Lynch;Robin K S Phillips;Marina H. Wallace

  • Chemopreventive Effect of Curcumin, a Naturally Occurring Anti-Inflammatory Agent, during the Promotion/Progression Stages of Colon Cancer

    Toshihiko Kawamori;Ronald Lubet;Vernon E. Steele;Gary J. Kelloff

  • Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development

    Gary J. Kelloff;John M. Hoffman;Bruce Johnson;Howard I. Scher

  • I‐SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy

    AD Barker;CC Sigman;GJ Kelloff;NM Hylton

  • The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.

    Russell F. Jacoby;Karen Seibert;Carolyn E. Cole;Gary Kelloff

  • Chemoprevention of Colon Cancer by Specific Cyclooxygenase-2 Inhibitor, Celecoxib, Administered during Different Stages of Carcinogenesis

    Bandaru S. Reddy;Yoshinobu Hirose;Ronald Lubet;Vernon Steele

  • Progress in Cancer chemoprevention : Development of diet-derived chemopreventive agents

    Gary J. Kelloff;James A. Crowell;Vernon E. Steele;Ronald A. Lubet

  • Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review.

    Charles W. Boone;Gary J. Kelloff;Winfred E. Malone

  • Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: A randomized placebo-controlled, double-blind trial

    Frank L. Meyskens;Christine E. McLaren;Daniel Pelot;Sharon Fujikawa-Brooks

  • Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development: Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia

    Joyce A. O’Shaughnessy;Gary J. Kelloff;Gary B. Gordon;Andrew J. Dannenberg

  • Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.

    Chinthalapally V. Rao;Abraham Rivenson;Barbara Simi;Edith Zang

  • A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis.

    R.K.S. Phillips;Marina Wallace;P.M. Lynch;E. Hawk

  • Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis.

    Susan M. Fischer;Herng-Hsang Lo;Gary B. Gordon;Karen Seibert

  • Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia: A Meta-analysis.

    Donald A. Berry;Shouhao Zhou;Howard Higley;Lata Mukundan

  • Modulation of Apoptosis by Sulindac, Curcumin, Phenylethyl-3-methylcaffeate, and 6-Phenylhexyl Isothiocyanate: Apoptotic Index as a Biomarker in Colon Cancer Chemoprevention and Promotion

    Hanan S. Samaha;Gary J. Kelloff;Vernon Steele;Chinthalapally V. Rao

  • Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development.

    Bandaru S. Reddy;Hiroshi Maruyama;Gary Kelloff

  • Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats

    Bandaru S. Reddy;Chinthalapally V. Rao;Abraham Rivenson;Gary Kelloff

  • Screening of Potential Chemopreventive Agents Using Biochemical Markers of Carcinogenesis

    Sheela Sharma;Jill D. Stutzman;Gary J. Kelloff;Vernon E. Steele

  • Perspectives on cancer chemoprevention research and drug development.

    Gary J. Kelloff

  • Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam

    Russell F. Jacoby;David J. Marshall;Michael A. Newton;Kristian Novakovic

Frequent Co-Authors

Vernon E. Steele
Vernon E. Steele National Institutes of Health
Ronald A. Lubet
Ronald A. Lubet National Institutes of Health
Bandaru S. Reddy
Bandaru S. Reddy Rutgers, The State University of New Jersey
Raymond V. Gilden
Raymond V. Gilden National Institutes of Health
Ming You
Ming You Medical College of Wisconsin
Chinthalapally V. Rao
Chinthalapally V. Rao University of Oklahoma Health Sciences Center
Gary D. Stoner
Gary D. Stoner The Ohio State University
Robert J. Huebner
Robert J. Huebner National Institutes of Health
Levy Kopelovich
Levy Kopelovich Cornell University
Scott M. Lippman
Scott M. Lippman University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine opens up various alternative educational options and related healthcare paths online. Many students opt for specialized programs like financial aid for medical billing and coding online classes. These programs provide a flexible and affordable way to enter the rapidly growing health information sector.

If you’re interested in nursing, there are accessible routes such as an lpn program without teas test. These pathways allow you to start your nursing journey without the hurdle of entrance exams, making it easier to begin your career.

For those aiming for leadership roles, consider a health administration degree. Earning this qualification online can quickly prepare you for management positions in hospitals, clinics, or other healthcare organizations.

Registered nurses looking to advance their qualifications might explore adn to msn bridge programs. These programs are designed to help ADN-prepared nurses earn a master’s degree efficiently, opening opportunities in advanced practice or administration.

Best Scientists Citing Gary J. Kelloff

Trending Scientists